Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders

por Schieber, Timothy, Li, Anthony, Lundberg, Jordan, Wiczer, Tracy, Voorhees, Timothy
Publicado 2023